ZIMMER BIOMET HOLDINGS, INC. is 13.5x more valuable than Cadre Holdings, Inc. by market capitalization ($17.06 B vs $1.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CDRE | ZBH |
|---|---|---|
| Market cap | $1.27 B | $17.06 B |
| US-listed rank | #2464 | #677 |
| Revenue (latest FY) | $610.31M | $8.23B |
| Net income (latest FY) | $44.14M | $705.10M |
| Net margin | 7.2% | 8.6% |
| P/E (trailing FY) | 28.7 | 24.2 |
| SEC filings | 380 | 1,000 |
ZIMMER BIOMET HOLDINGS, INC. is 13.5x more valuable than Cadre Holdings, Inc. by market capitalization ($17.06 B vs $1.27 B).
In their latest fiscal years, Cadre Holdings, Inc. reported $610.31M in revenue while ZIMMER BIOMET HOLDINGS, INC. reported $8.23B.
Full pages: Cadre Holdings, Inc. and ZIMMER BIOMET HOLDINGS, INC., or browse the full rankings.